Epic Build / Desired Build Test Compendium
Welcome to the new Northwell Health Labs Epic Build / Desired Build Test Directory! Please email ClinicalLabInformatics@northwell.edu with any typos, corrections or issues.

OnkoSight Advanced Chronic Lymphoid Neoplasm Epic Compendium  

Desired Epic Build * = editable field  

Actual Epic Build 11/20/2025

PROCEDURE ID 137023
PDM 235442
ORDER DISPLAY NAME OnkoSight Advanced Chronic Lymphoid Neoplasm
PROCEDURE NAME ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASM
PROCEDURE MASTER NUMBER LAB12276
SHORT PROCEDURE NAME OnkoSight Advanced Chronic Lymphoid Neoplasm
CATEGORY CODE 1.0
CATEGORY CODE RECORD NAME LAB BLOOD ORDERABLES
SYNONYMS ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASMA NGS
OSACLN
ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASMA N
CLINICALLY ACTIVE Yes
ORDERABLE Yes
PERFORMABLE Yes
FILTER GENOMICS Generic Genomics Procedure
REFERENCE LINK URL https://labs.northwell.edu/epic/test/137023
ORDERING INSTRUCTIONS
DEFAULT SPECIMEN TYPE Blood
SPECIMEN TYPE PICK LIST Bone Marrow
Blood
Aspirate
SPECIMEN TYPE LIST
OP SPECIMEN TYPE LIST
SPECIMEN SOURCE PICK LIST Blood, Arterial
Blood, Capillary
Blood, Central Line
Blood, Venous
Bone Marrow Aspirate
Bone Marrow
SPECIMEN SOURCE DEFAULT - MALE Blood, Venous
SPECIMEN SOURCE DEFAULT - FEMALE Blood, Venous
SPECIMEN SOURCE LIST
OP SPECIMEN SOURCE LIST
IP LAB TEST COMPONENTS FOR REPORT ADDENDUM
CLINTRIAL
DETAILGENINT
METHODS
ONKOACHLYM
ONKOSIGHTINT
REF1
REF2
RPTFOOTER
SPECAPPEAR
TECHSUM
THERPROGASS
OP LAB TEST COMPONENTS FOR REPORT ADDENDUM
CLINTRIAL
DETAILGENINT
METHODS
ONKOACHLYM
ONKOSIGHTINT
REF1
REF2
RPTFOOTER
SPECAPPEAR
TECHSUM
THERPROGASS
ORDER QUESTIONS []
ORDER QUESTIONS RECORD NAME
INPATIENT ORDER QUESTIONS []
INPATIENT ORDER QUESTIONS RECORD NAME
ORDER SPECIFIC QUESTION OVERRIDE Yes
INPATIENT QUESTION OVERRIDE
LOCATION RESTRICT LIST IP
LOCATION RESTRICT LIST IP RECORD NAME
LOCATION RESTRICT LIST INCLUDE IP
LOCATION RESTRICT LIST OP
LOCATION RESTRICT LIST OP RECORD NAME
LOCATION RESTRICT LIST INCLUDES OP
EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME
EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME
EDP IP SPECIMEN SOURCE Blood, Venous
Blood, Central Line
Blood, Arterial
Blood, Capillary
Blood, Peripheral
EDP OP SPECIMEN SOURCE
EDP IP SPECIMEN TYPE Blood
EDP OP SPECIMEN TYPE
DERIVED EDP IP BUTTONS S Blood, Venous
Blood, Arterial
Blood, Central Line
Blood, Capillary
DERIVED EDP IP BUTTONS T Blood
DERIVED EDP OP BUTTONS S
DERIVED EDP OP BUTTONS T
IP ORDERABLE 1
OP ORDERABLE 1
STANDARD LAB COMPONENTS
STANDARD LAB COMPONENTS RECORD NAME
COMPONENT DATA REQUIREMENT
EPIC OP AOEs

EPIC IP AOEs

EPIC Components (results - crosswalked through Cerner)

Component IDComponent NameBase NameCommon NameExternal NameCerner Result PDM
3047804921.0 TECHNICAL SUMMARY : TECHSUM TECHNICAL SUMMARY Technical Summary: 237540G
3047804494.0 REFERENCES 2 REF2 REFERENCES 2 References 2 237540J
3046001803.0 ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOP ONKOACHLYM ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOP OnkoSight Advanced Chronic Lymphoid Neop 235442
3047804493.0 REFERENCES 1 REF1 REFERENCES 1 References 1 237540I
3048100147.0 REPORT FOOTER RPTFOOTER REPORT FOOTER Report Footer 237540K
3047808457.0 GENES GENES GENES Genes 235442A
3047808455.0 COMMENTS (REF LAB) COMMENTREF COMMENTS REF LAB Comments (Ref lab) 225004C
3048100148.0 METHODS METHODS METHODS Methods 237540H
3047808458.0 REFERRING PHYSICIAN REFMD REFERRING PHYSICIAN Referring Physician 235442B
3046008585.0 IMAGE IMAGE IMAGE Image 235442D
3047801844.0 CLINICAL TRIALS 1 : CLINTRIAL CLINICAL TRIALS 1 Clinical Trials 1: 237540E
3047801845.0 CLINICAL TRIALS 2 : CLINTRIAL CLINICAL TRIALS 2 Clinical Trials 2: 237540F
3047808520.0 METHOD/LIMITATIONS METHODLIMIT METHOD LIMITATIONS Method/Limitations 255345H
3047808459.0 APPENDIX-CLINICAL TRIALS APPENDIXCT APPENDIX CLINICAL TRIALS Appendix-Clinical Trials 235442C
3047804491.0 REFERENCES REFERENCES REFERENCES References 5910709
3047800865.0 ADDENDUM : ADDENDUM ADDENDUM Addendum: 237540L
3047808516.0 RESULT: RESULT RESULT Result: 255345D
3047802137.0 DETAILED GENETIC INTERPRETATION 2 : DETAILGENINT DETAILED GENETIC INTERPRETATION 2 Detailed Genetic Interpretation 2 : 237540D
3047808522.0 INDICATION INDICATION INDICATION Indication 255345J
3047808460.0 RELEASED BY: RELEASEDONK RELEASED BY Released By 235442E
3047808454.0 INTERPRETATION: INTERP INTERPRETATION Interpretation: 1559011F
3047802136.0 DETAILED GENETIC INTERPRETATION 1 DETAILGENINT DETAILED GENETIC INTERPRETATION 1 Detailed Genetic Interpretation 1 237540C
3047804957.0 THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS THERPROGASS THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS Therapeutic and Prognostic Associations 237540A
3047803091.0 INTERPRETATION SUMMARY ONKOSIGHTINT INTERPRETATION SUMMARY Interpretation Summary 237540B
3047808515.0 SPECIMEN TYPE - LC SPECTYPE SPECIMEN TYPE Specimen Type - LC 255345B